Complement Inhibitors [MoA] - N0000175974

Pharmacologic Class Information

Pharmacologic Code N0000175974
Pharmacologic Name Complement Inhibitors
Pharmacologic Uses
  • complement inhibitor
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Complement Inhibitors

The table contains 11 products whose active ingredient are classified under the same pharmacologic class Complement Inhibitors [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
25682-001Soliris Non-Proprietary Name: EculizumabInjection, Solution, ConcentrateIntravenousAlexion Pharmaceuticals Inc.ACTIVE
25682-022Ultomiris Non-Proprietary Name: RavulizumabSolution, ConcentrateIntravenousAlexion Pharmaceuticals Inc.ACTIVE
25682-025Ultomiris Non-Proprietary Name: RavulizumabSolution, ConcentrateIntravenousAlexion Pharmaceuticals Inc.ACTIVE
25682-028Ultomiris Non-Proprietary Name: RavulizumabSolution, ConcentrateIntravenousAlexion Pharmaceuticals Inc.ACTIVE
50474-990Zilbrysq Non-Proprietary Name: ZilucoplanInjection, SolutionSubcutaneousUcb, Inc.ACTIVE
50474-991Zilbrysq Non-Proprietary Name: ZilucoplanInjection, SolutionSubcutaneousUcb, Inc.ACTIVE
50474-992Zilbrysq Non-Proprietary Name: ZilucoplanInjection, SolutionSubcutaneousUcb, Inc.ACTIVE
61755-014Veopoz Non-Proprietary Name: PozelimabInjection, SolutionIntravenous; SubcutaneousRegeneron Pharmaceuticals, Inc.ACTIVE
73606-010Empaveli Non-Proprietary Name: PegcetacoplanInjection, SolutionSubcutaneousApellis Pharmaceuticals, Inc.ACTIVE
73606-020Syfovre Non-Proprietary Name: PegcetacoplanInjection, SolutionIntravitrealApellis Pharmaceuticals, Inc.ACTIVE
82829-002Izervay Non-Proprietary Name: Avacincaptad PegolInjectionIntravitrealAstellas Pharma Us, Inc.ACTIVE